• In this study, the authors will collect data on vital signs and neurological deficits within 24 hours of admission, 3 days and 7 days after admission, and at discharge. However, the timing of data collection should be standardized based on the time of stroke onset but not the time of admission.
• This study plans to enroll stroke patients who are hospitalized within 30 days of stroke onset in nine participating hospitals. Consequently, this registry includes not only stroke patients in the acute stage but also those in the chronic stage. Are stroke patients in the chronic stage also referred to tertiary hospitals in China? To elucidate the clinical features of severe ischemic stroke, the study subjects should be restricted to patients with acute stroke.
• The authors mention only some examples as to data in each item in Table 1 . Please describe the variables more in detail. Furthermore, their definitions would be needed.
• Pre-stroke dependency has a significant impact on the poststroke functional status and mortality. Activities of daily living before stroke onset should be investigated to control the prestroke functional status in stroke patients.
• It should be difficult for patients with impaired consciousness or coma to consent to the participation in this study. Will the authors obtain written informed consent from their proxy in such cases? Please clarify this point.
Minor comments • To eliminate selection bias, all consecutive patients would need to be included in the registry. Are all patients with severe stroke hospitalized in the department of Neurology irrespective of the indications for neurosurgery? According to the exclusion criteria shown in the Methods section, this study will not include "patients who are likely to be unavailable for follow-up". This may cause serious bias in patient selection. How much do the authors estimate the rate of participation or follow-up? • Severe stroke is defined as the NIHSS score ≥15. When is it diagnosed? Baseline severity should be evaluated as early as possible after stroke onset. Additionally, the accuracy of the score is important to avoid misclassification. Who will assess the NIHSS score?
• How long is the length of hospital stay in patients with ischemic stroke in China? Such information would be helpful for the readers to better understand the study protocol.
• How will the authors handle missing data?
• Please clarify the definitions of symptomatic hemorrhagic transformation and brain edema. Brain edema is possibly found in almost all patients with severe ischemic stroke. Moreover, hemorrhagic transformation often develops after cardioembolic stroke secondary to spontaneous reopening of the occluded artery. Does "symptomatic" indicate a ≥1-point increase in the NIHSS score?
• Does mortality include death from any cause?
• Continuous variables will be compared by Student t-test or oneway ANOVA. However, these tests are not suitable for the analysis of data which are not normally distributed.
• A certain proportion of patients may be lost during the follow-up. Therefore, survival analysis, such as proportional hazards model, would be better to analyze 1-year mortality than logistic regression model.
VERSION 1 -AUTHOR RESPONSE
Reviewer comments and our responses Reviewer 1 Comment 1. The authors aim to include 2500 patients. When will the study start en when do they estimate to include the final patient? How many patients per year are eligible for inclusion?
Our responses: the study started in March 2017 and will end in February 2020 (as we reported in the first sentence of the METHODS AND ANALYSIS section, page 7). Approximately 1500 patients with acute ischaemic stroke are admitted to the nine participating hospitals each year, so it is feasible to include 2500 in two to three years' time.
Comment 2. In the abstract (methods section), it is unclear how severe stroke patients are selected from the total group of included patients. Please clarify Our responses: we had defined 'severe ischaemic stroke' and three groups of patients according to their clinical course (under subheading 'Participants-Definition of severe ischaemic stroke' in the METHODS AND ANALYSIS section, page 9). Patients with either 'initially severe stroke' or 'latedeveloped severe stroke' are 'severe stroke patients'. We added the following text to clarify this issue in the ABSTRACT: 'Severe stroke is defined as severe neurological deficits (National Institute of Health Stroke Scale [NIHSS] ≥15 or in coma) on admission or clinical worsening (NIHSS increased by ≥4 scores) during hospitalisation.' Comment 3. In Figure 1 , there seems to be an Arrow that is misplaced. I assume that the error between 'exclusion:...' and 'non-severe stroke group', should be placed between 'severe stroke group....' and 'non-severe stroke group'.
Our responses: Thank you for pointing out this mistake. The arrow should be placed from 'Inclusion criteria…' to 'non-severe stroke group'. We have corrected it in Figure 1 .
Comment 4. I would recommend a long-term follow up at 3 years;
Comment 5. I would recommend to include quality-of-life outcomes at 1 and 3 years Our responses to comments 4 and 5: we appreciate the reviewer's advice that long-term follow-up and quality of life are important for stroke patients. We discussed within our Central Management Team and reported to the Steering Committee; however, we have limited funding and personnel to complete such assessment. Existing tools for assessing quality of life in stroke patients, such as EQ-5D, SF-36, SSQoL and Stroke Impact Scale, would require specialized training and take longer time for assessment than modified Rankin scale that we use, thus may not be feasible within current study framework where the follow-up assessment for 2500 participants is conducted by busy neurologists and medical postgraduate students. We will consider this suggestion for further funding application, and if further funding is provided to support longer follow-up and employment of research staff, we will incorporate the reviewer's suggestions to modify our follow-up plan. As in most stroke studies, one year follow-up of survival status and independence would be sufficient to inform patients, families and doctors of possible prognosis. We do hope the reviewer can understand our situation with the limited budget, personnel and study period.
Comment 6. In the Introduction section, the definition of 'severe stroke should be made clear'.
Our responses: we have modified the wording in the first paragraph of the Introduction to clarify this definition (Please see the text highlighted in red, page 5). Further definition is provided in the Methods section (page 9).
Reviewer 2
Major comment 1: In this study, the authors will collect data on vital signs and neurological deficits within 24 hours of admission, 3 days and 7 days after admission, and at discharge. However, the timing of data collection should be standardized based on the time of stroke onset but not the time of admission.
Major comment 2:
This study plans to enroll stroke patients who are hospitalized within 30 days of stroke onset in nine participating hospitals. Consequently, this registry includes not only stroke patients in the acute stage but also those in the chronic stage. Are stroke patients in the chronic stage also referred to tertiary hospitals in China? To elucidate the clinical features of severe ischemic stroke, the study subjects should be restricted to patients with acute stroke.
Our responses to comments 1 and 2: yes, some stroke patients, especially those with severe stroke and treated in lower level hospitals but do not improve, will be referred to tertiary hospitals for further management, even some have passed the acute phase. We agree with the reviewer that patients during acute phase are best to elucidate the clinical features of severe ischaemic stroke; however, given about 20% of stroke patients in tertiary hospitals are admitted after 7 days of stroke onset, we are interested to learn the clinical features of these patients and explore the management interventions for them.
The same situation applies to Comment 1 regarding the timing of data collection. We include patients within 30 days after onset because this reflects the reality that neurologists in tertiary hospitals in China encounter in practice. Given a broad range of 30 days, it is less feasible to standard the timing of data collection according to the time since stroke onset. To resolve the reviewer's concern, we will perform a subgroup analysis for patients who are admitted within 24 hours after stroke (which comprises about 30% of the entire cohort) to elucidate the clinical course and other features of severe stroke (please see the first paragraph of 'Provisional analysis plan' in METHODS AND ANALYSIS section, page 14).
Major comment 3:
The authors mention only some examples as to data in each item in Table 1 . Please describe the variables more in detail. Furthermore, their definitions would be needed.
Our responses: as the reviewer suggested, we provided more details and definitions in the text (see second paragraph under subheading 'In-hospital visits and data collection' in the METHODS AND ANALYSIS section, pages 10-11).
Major comment 4:
Pre-stroke dependency has a significant impact on the post-stroke functional status and mortality. Activities of daily living before stroke onset should be investigated to control the pre-stroke functional status in stroke patients.
Our responses: we will assess patients' ability in daily activities prior to current stroke by modified Rankin scale. This information has been added in the second paragraph under subheading 'Inhospital visits and data collection' in the METHODS AND ANALYSIS section, page 10.
Major comment 5: It should be difficult for patients with impaired consciousness or coma to consent to the participation in this study. Will the authors obtain written informed consent from their proxy in such cases? Please clarify this point.
Our responses: for patients who are incapable in understanding the study and providing written consent, which is common for those with severe stroke or depressed consciousness, we will seek consent from their legal proxies. Assessment of stroke patients' capacity in communication and making medical decisions for themselves is a routine procedure by their responsible doctors, who are also in charge of informing and obtaining consent from patients or their proxies for current study. In practice, families will be required to sign the power of attorney to be the legal proxies of patients with incapacity. We reported that the informed consent would be obtained from either patients or their legal proxies (in the paragraph of 'Inclusion and exclusion criteria' under subheading of 'Participants' in the METHODS AND ANALYSIS section, page 8).
Minor comment 1: To eliminate selection bias, all consecutive patients would need to be included in the registry. Are all patients with severe stroke hospitalized in the department of Neurology irrespective of the indications for neurosurgery? According to the exclusion criteria shown in the Methods section, this study will not include "patients who are likely to be unavailable for follow-up". This may cause serious bias in patient selection. How much do the authors estimate the rate of participation or follow-up?
Our responses: patients with severe ischaemic stroke are admitted to the department of Neurology including some require immediate surgery after admission, with less than 1% may be admitted immediately to the department of Neurology. Due to organizational and administrative difficulties, we are unable to include this small proportion of patients. We excluded "patients who are likely to be unavailable for follow-up, e.g. no fixed home address" because the participating hospitals serve patients from remote villages and some have no fixed home address and even phone numbers. Thus for such patients we are unable to obtain their follow-up information. Based on our ongoing stroke registry, the rate of participation is 90% of all admitted patients and rate of loss to follow-up at 1 year is 10% of all participants (as we stated in the Sample size estimation, page 16).
Minor comment 2:
Severe stroke is defined as the NIHSS score ≥15. When is it diagnosed? Baseline severity should be evaluated as early as possible after stroke onset. Additionally, the accuracy of the score is important to avoid misclassification. Who will assess the NIHSS score?
Our responses: the NIHSS score is assessed by the on-site neurologists or trained postgraduate students at each participating centre (mainly the responsible doctors of the patients), at day 0, day 3, day 7 and at discharge (please see Table 1 ). The initial assessment of NIHSS is usually completed within the first hour after admission in practice, which we record for day 0. For clarity, we added this information in the first sentence under subheading 'In-hospital visits and data collection' in METHODS AND ANALYSIS section, page 10.
Minor comment 3:
How long is the length of hospital stay in patients with ischemic stroke in China? Such information would be helpful for the readers to better understand the study protocol.
Our responses: the average hospital stay of patients with ischaemic stroke in tertiary hospital is about 2 weeks, and longer in secondary or lower level hospitals. For some patients with severe stroke, the stay can be longer up to 30 days or more. We clarified this in the paragraph under subheading 'Inhospital visits and data collection' in METHODS AND ANALYSIS section, page 10.
Minor comment 4: How will the authors handle missing data?
Our responses: thank you for reminding us of this issue. We will adopt two approaches to handle missing data: a) we will perform multiple imputation to account for missing data, and b) we will perform sensitivity analysis by excluding patients with missing data. We have added this information in the paragraph of statistical analysis under the subheading 'Provisional analysis plan' in METHODS AND ANALYSIS section, page 16.
Minor comment 5:
Please clarify the definitions of symptomatic hemorrhagic transformation and brain edema. Brain edema is possibly found in almost all patients with severe ischemic stroke. Moreover, hemorrhagic transformation often develops after cardioembolic stroke secondary to spontaneous reopening of the occluded artery. Does "symptomatic" indicate a ≥1-point increase in the NIHSS score?
Our responses: we define symptomatic haemorrhagic transformation as significant clinical worsening accompanied by clear evidence of significant intracranial haemorrhage on the brain scan, and symptomatic brain oedema as significant clinical worsening accompanied by evidence of significant brain swelling including shift of the midline away from the side of the ventricle or effacement of the basal cisterns or uncal herniation on the brain scan. We have clarified the definition in the paragraph under subheading 'Clinical outcomes' in METHODS AND ANALYSIS section, pages 11-12.
We defined clinical worsening as a) neurological deterioration with an increase of NIHSS score of 4 or more as compared to baseline NIHSS, b) a decline of consciousness, which leads to a GCS score of 8 or less, or item 1a of NIHSS scored 1 or over, c) need for invasive interventions such as DHC, or d) death in hospital (please see the second paragraph of 'Definition of severe ischaemic stroke' under subheading of 'Participants' in the METHODS AND ANALYSIS section, page 9).
Minor comment 6: Does mortality include death from any cause?
Our responses: yes, we include death from any cause for mortality. In addition, we will record the cause for death to perform subgroup analysis (in the paragraph of 'Follow-up assessments' in METHODS AND ANALYSIS section, page 11).
Minor comment 7:
Continuous variables will be compared by Student t-test or one-way ANOVA. However, these tests are not suitable for the analysis of data which are not normally distributed.
Our responses: thank you for pointing out this issue. We have revised this part as follows: 'Two group comparisons will be conducted by independent Student-t test or Mann-Whitney test for continuous variables' (in the paragraph of 'Statistical analyses' under subheading 'Provisional analysis plan' in METHODS AND ANALYSIS section, page 15).
Minor comment 8:
A certain proportion of patients may be lost during the follow-up. Therefore, survival analysis, such as proportional hazards model, would be better to analyze 1-year mortality than logistic regression model. Our responses: thank you for your advice. We have added the relevant information in the 'Provisional analysis plan': 'Cox proportional hazard model will be used to explore factors affecting prognosis at 3 months and 1 year' (line 2, page 16).
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